{"id":8785,"date":"2025-12-02T23:02:25","date_gmt":"2025-12-02T23:02:25","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/12\/02\/richard-pazdur-cder-director-fda-set-to-retire\/"},"modified":"2025-12-02T23:02:25","modified_gmt":"2025-12-02T23:02:25","slug":"richard-pazdur-cder-director-fda-set-to-retire","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/12\/02\/richard-pazdur-cder-director-fda-set-to-retire\/","title":{"rendered":"STAT+: Top drug regulator Richard Pazdur set to leave the FDA"},"content":{"rendered":"<p>    STAT+: Top drug regulator Richard Pazdur set to leave the FDA<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p>WASHINGTON \u2014 Top drug regulator Richard Pazdur has filed papers to retire from the Food and Drug Administration at the end of this month, adding to the turmoil atop the agency.<\/p>\n<p>Pazdur informed leaders at the FDA\u2019s drug center of his intention to leave the agency at a meeting on Tuesday, according to two agency sources familiar with the matter. The move comes less than a month after <a href=\"https:\/\/www.statnews.com\/2025\/11\/11\/fda-picks-richard-pazdur-director-center-for-drug-evaluation-and-research\/\">he took the role<\/a> of top drug regulator at the urging of FDA Commissioner Marty Makary.<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/12\/02\/richard-pazdur-cder-director-fda-set-to-retire\/?utm_campaign=rss\">Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Lizzy Lawrence<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/12\/02\/richard-pazdur-cder-director-fda-set-to-retire\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STAT+: Top drug regulator Richard Pazdur set to leave the FDA WASHINGTON \u2014 Top drug regulator Richard Pazdur has filed papers to retire from the Food and Drug Administration at the end of this month, adding to the turmoil atop the agency. Pazdur informed leaders at the FDA\u2019s drug center of his intention to leave [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2154,2216,2181,2146,1428,2176,2155,2151,2144,2152],"tags":[2150],"class_list":["post-8785","post","type-post","status-publish","format-standard","hentry","category-biotechnology","category-breaking-news","category-exclusive","category-fda","category-health","category-pharma","category-pharmaceuticals","category-policy","category-politics","category-stat","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/8785"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=8785"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/8785\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=8785"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=8785"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=8785"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}